ArticleScience advances2022

Combinations of anti-GITR antibody and CD28 superagonist induce permanent allograft acceptance by generating type 1 regulatory T cells.

Weitao Que et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.